Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

New compounds were made that are promising for prostate cancer therapy.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Dutasteride reduces DHT more effectively than finasteride.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

Targeting ornithine decarboxylase can help prevent skin cancer.

Upadacitinib may effectively treat resistant lichen planopilaris.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Paroxetine relieves pain by increasing allopregnanolone levels.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Upadacitinib effectively treats pyoderma gangrenosum.

Analog 23 is a promising compound for prostate cancer treatment.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

New compounds may help treat prostate cancer by reducing cell growth.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.